RadioNano Therapeutics Inc. have been certified as a 'Kyoto City A-Rank Recognized Company' by the 65th Kyoto City Venture Enterprise Screening Committee for fiscal year 2025.

The Kyoto City Venture Enterprise Screening Committee is a program established by the City of Kyoto to discover and nurture venture companies that will drive the industries of the next generation, comprehensively evaluating new business plans based on criteria such as novelty, business viability, market potential, and management philosophy.

In this screening, we received high recognition for the novelty and innovation of our proprietary RN-501 technology, as well as the uniqueness of our business plan, its feasibility, market potential, and our passion for the business — leading to our certification at the A-Rank level.

Going forward, we remain committed to contributing to industrial development through innovative technological advancement, while continuing to help more companies and organizations solve their challenges.

At the 65th Session (63rd Term) of the Kyoto City Venture Enterprise Screening Committee, eight companies were newly certified at the A-Rank level. | Kyoto City Venture Enterprise Screening Committee